Preoperative plasma N-terminal pro-brain natriuretic peptide as a marker of cardiac risk in patients undergoing elective non-cardiac surgery

被引:64
作者
Yeh, HM
Lau, HP
Lin, JM
Sun, WZ
Wang, MJ
Lai, LP
机构
[1] Natl Taiwan Univ Hosp, Dept Anaesthesiol, Taipei, Taiwan
[2] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan
[3] Natl Taiwan Univ Hosp, Inst Pharmacol, Taipei, Taiwan
[4] Keelung Hosp, Dept Internal Med, Dept Hlth Execut Yuan, Chilung, Taiwan
关键词
D O I
10.1002/bjs.4947
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background: Plasma N-terminal pro-brain natriuretic peptide (NTproBNP) is a sensitive marker for heart failure. This study tested whether the preoperative plasma level of NTproBNT could predict cardiac complications in patients undergoing non-cardiac surgery. Methods: A total of 190 consecutive patients who underwent elective non-cardiac surgery that required general anaesthesia were studied. In addition to routine preoperative evaluation, a blood sample was taken for estimation of plasma NTproBNP concentration. Postoperative cardiac complications were defined as cardiac death, acute coronary syndrome, heart failure and haemodynamic compromise from cardiac arrhythmias. Results: Fifteen of the 190 patients had a cardiac complication: four had acute coronary syndrome and 13 had congestive heart failure. NTproBNP concentration was significantly higher in patients with a cardiac complication; a level greater than 450 ng/l was predictive of cardiac complications with a sensitivity of 100 per cent and a specificity of 82.9 per cent. Other factors associated with cardiac complications were a higher American Society of Anesthesiologists grade, age and clinical cardiac impairment, but in a multivariate analysis NTproBNP level was the only independent factor. Conclusion: Preoperative plasma NTproBNP concentration may be an independent predictor of cardiac complications in patients undergoing non-cardiac surgery.
引用
收藏
页码:1041 / 1045
页数:5
相关论文
共 27 条
[1]   NT-proBNP: a new diagnostic screening tool to differentiate between patients with normal and reduced left ventricular systolic function [J].
Bay, M ;
Kirk, V ;
Parner, J ;
Hassager, C ;
Nielsen, H ;
Krogsgaard, K ;
Trawinski, J ;
Boesgaard, S ;
Aldershvile, J .
HEART, 2003, 89 (02) :150-154
[2]   PREDICTING CARDIAC COMPLICATIONS IN PATIENTS UNDERGOING NONCARDIAC SURGERY [J].
DETSKY, AS ;
ABRAMS, HB ;
MCLAUGHLIN, JR ;
DRUCKER, DJ ;
SASSON, Z ;
JOHNSTON, N ;
SCOTT, JG ;
FORBATH, N ;
HILLIARD, JR .
JOURNAL OF GENERAL INTERNAL MEDICINE, 1986, 1 (04) :211-219
[3]  
Eagle KA, 1996, J AM COLL CARDIOL, V27, P910
[4]   MULTIFACTORIAL INDEX OF CARDIAC RISK IN NON-CARDIAC SURGICAL PROCEDURES [J].
GOLDMAN, L ;
CALDERA, DL ;
NUSSBAUM, SR ;
SOUTHWICK, FS ;
KROGSTAD, D ;
MURRAY, B ;
BURKE, DS ;
OMALLEY, TA ;
GOROLL, AH ;
CAPLAN, CH ;
NOLAN, J ;
CARABELLO, B ;
SLATER, EE .
NEW ENGLAND JOURNAL OF MEDICINE, 1977, 297 (16) :845-850
[5]   Detection of left ventricular enlargement and impaired systolic function with plasma N-terminal pro brain natriuretic peptide concentrations [J].
Groenning, BA ;
Nilsson, JC ;
Sondergaard, L ;
Pedersen, F ;
Trawinski, J ;
Baumann, M ;
Larsson, HBW ;
Hildebrandt, PR .
AMERICAN HEART JOURNAL, 2002, 143 (05) :923-929
[6]   Echocardiography for assessing cardiac risk in patients having noncardiac surgery [J].
Halm, EA ;
Browner, WS ;
Tubau, JF ;
Tateo, IM ;
Mangano, DT .
ANNALS OF INTERNAL MEDICINE, 1996, 125 (06) :433-441
[7]   Head-to-head comparison of N-terminal pro-brain natriuretic peptide, brain natriuretic peptide and N-terminal pro-atrial natriuretic peptide in diagnosing left ventricular dysfunction [J].
Hammerer-Lercher, A ;
Neubauer, E ;
Müller, S ;
Pachinger, O ;
Puschendorf, B ;
Mair, J .
CLINICA CHIMICA ACTA, 2001, 310 (02) :193-197
[8]   EXPRESSION OF BRAIN NATRIURETIC PEPTIDE GENE IN HUMAN HEART - PRODUCTION IN THE VENTRICLE [J].
HOSODA, K ;
NAKAO, K ;
MUKOYAMA, M ;
SAITO, Y ;
JOUGASAKI, M ;
SHIRAKAMI, G ;
SUGA, S ;
OGAWA, Y ;
YASUE, H ;
IMURA, H .
HYPERTENSION, 1991, 17 (06) :1152-1156
[9]   Immunoreactive amino-terminal pro-brain natriuretic peptide (NT-PROBNP): A new marker of cardiac impairment [J].
Hunt, PJ ;
Richards, AM ;
Nicholls, MG ;
Yandle, TG ;
Doughty, RN ;
Espiner, EA .
CLINICAL ENDOCRINOLOGY, 1997, 47 (03) :287-296
[10]   N-terminal pro brain natriuretic peptide on admission for early risk stratification of patients with chest pain and no ST-segment elevation [J].
Jernberg, T ;
Stridsberg, M ;
Venge, P ;
Lindahl, B .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2002, 40 (03) :437-445